Gaithersburg, Maryland, United States
Contact Info
1K followers
500+ connections
Gaithersburg, Maryland, United States
Contact Info
1K followers
500+ connections
About
Frank is an investor focusing on discovering opportunities in the pharmaceutical/biotech…
Activity
-
Very encouraging clinical data yesterday from IDEAYA Biosciences on their first-in-class MAT2A inhibitor in MTAP-deleted NSLC and urothelial cancer…
Very encouraging clinical data yesterday from IDEAYA Biosciences on their first-in-class MAT2A inhibitor in MTAP-deleted NSLC and urothelial cancer…
Liked by Fayong "Frank" Luo
-
Flagship and GSK announce a strategic collaboration to discover and develop a portfolio of novel medicines and vaccines, starting in respiratory and…
Flagship and GSK announce a strategic collaboration to discover and develop a portfolio of novel medicines and vaccines, starting in respiratory and…
Liked by Fayong "Frank" Luo
-
Boehringer Ingelheim is excited to announce our acquisition of Nerio Therapeutics, which brings an innovative, preclinical small molecule program…
Boehringer Ingelheim is excited to announce our acquisition of Nerio Therapeutics, which brings an innovative, preclinical small molecule program…
Liked by Fayong "Frank" Luo
Experience & Education
-
Simcere Zaiming
View Fayong "Frank"’s full experience
See their title, tenure and more.
or
Volunteer Experience
-
Interpreter and Organizer
BringMeHope Foundation
- 2 years 1 month
Children
More activity by Fayong "Frank"
-
We have just entered into an exciting new deal with Flagship Pioneering that highlights our focus on harnessing the latest external advances in…
We have just entered into an exciting new deal with Flagship Pioneering that highlights our focus on harnessing the latest external advances in…
Liked by Fayong "Frank" Luo
-
Today we announced that we have acquired Elsie Biotechnologies to further advance our capabilities in the discovery and development of novel…
Today we announced that we have acquired Elsie Biotechnologies to further advance our capabilities in the discovery and development of novel…
Liked by Fayong "Frank" Luo
-
In the past weeks, I had the pleasure to visit MSD China offices in Beijing and Shanghai. Really enjoyed meeting the bright and friendly statistician…
In the past weeks, I had the pleasure to visit MSD China offices in Beijing and Shanghai. Really enjoyed meeting the bright and friendly statistician…
Liked by Fayong "Frank" Luo
-
I am excited to announce that I have joined the External Innovation team at Lilly, where I will be focusing on our Immunology BD and Partnering…
I am excited to announce that I have joined the External Innovation team at Lilly, where I will be focusing on our Immunology BD and Partnering…
Liked by Fayong "Frank" Luo
-
Pharma Partnering Summit is delighted to introduce Beatriz (Bea) Gadala-Maria, Senior Director, Transactions, Oncology R&D Business Development &…
Pharma Partnering Summit is delighted to introduce Beatriz (Bea) Gadala-Maria, Senior Director, Transactions, Oncology R&D Business Development &…
Liked by Fayong "Frank" Luo
-
We are pleased to partner with Hengrui AGAIN (after the 2021 CTLA4 deal) to commercialize the precision therapy AYVAKIT® (avapritinib tablets) in…
We are pleased to partner with Hengrui AGAIN (after the 2021 CTLA4 deal) to commercialize the precision therapy AYVAKIT® (avapritinib tablets) in…
Liked by Fayong "Frank" Luo
-
I’m happy to share that in addition to my current role leading the Biologics Engineering and Targeted Delivery groups, I will be heading the newly…
I’m happy to share that in addition to my current role leading the Biologics Engineering and Targeted Delivery groups, I will be heading the newly…
Liked by Fayong "Frank" Luo
-
Richard Ward is a Executive Director in the Oncology Search & Evaluation Group in AstraZeneca. In this role, he is responsible for the identification…
Richard Ward is a Executive Director in the Oncology Search & Evaluation Group in AstraZeneca. In this role, he is responsible for the identification…
Liked by Fayong "Frank" Luo
-
Congratulations to Senti Biosciences for being awarded $8M from the California Institute for Regenerative Medicine (CIRM) for the Logic-Gated…
Congratulations to Senti Biosciences for being awarded $8M from the California Institute for Regenerative Medicine (CIRM) for the Logic-Gated…
Liked by Fayong "Frank" Luo
-
Do you remember what you were doing ten years ago today? It’s hard to believe it’s been that long, but I was starting my first day at AstraZeneca. I…
Do you remember what you were doing ten years ago today? It’s hard to believe it’s been that long, but I was starting my first day at AstraZeneca. I…
Liked by Fayong "Frank" Luo
-
This week my colleagues and I visited the AstraZeneca Hope Lodge in Boston, a place offering a free home away from home for #cancer patients and…
This week my colleagues and I visited the AstraZeneca Hope Lodge in Boston, a place offering a free home away from home for #cancer patients and…
Liked by Fayong "Frank" Luo
-
It was a privilege to deliver a keynote speech on AstraZeneca’s oncology R&D strategy at the Chinese Biopharmaceutical Association 29th Annual…
It was a privilege to deliver a keynote speech on AstraZeneca’s oncology R&D strategy at the Chinese Biopharmaceutical Association 29th Annual…
Liked by Fayong "Frank" Luo
-
Enlituo® (generic name: cetuximab beta injection), a new generation EGFR antibody drug that Simcere Zaimimg collaborated with Mabpharm Limited…
Enlituo® (generic name: cetuximab beta injection), a new generation EGFR antibody drug that Simcere Zaimimg collaborated with Mabpharm Limited…
Liked by Fayong "Frank" Luo
-
Thrilled to have worked on this with the AZ team, and to have been across the table from old and new faces! 🥳 Abigail Gregor Nicole E. Rohr, PhD…
Thrilled to have worked on this with the AZ team, and to have been across the table from old and new faces! 🥳 Abigail Gregor Nicole E. Rohr, PhD…
Liked by Fayong "Frank" Luo
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More